Kimura Y - Search Results

1

[A case of gastric cancer showing a durable response after the discontinuation of nivolumab due to the early onset of immune-related adverse events].

Tomita Y, Mori Y, Kanaiwa H, Yamaguchi A, Kitagawa M, Nomura S, Hirano A, Kimura Y, Tsuchida K, Seno K. Tomita Y, et al. Among authors: kimura y. Nihon Shokakibyo Gakkai Zasshi. 2022;119(6):551-557. doi: 10.11405/nisshoshi.119.551. Nihon Shokakibyo Gakkai Zasshi. 2022. PMID: 35691925 Japanese.

2

[A case of malignant tumor of the ascending part of duodenum with osteoclast-like giant cells].

Hirano A, Tsuchida K, Nakamura M, Adachi K, Inagaki Y, Yamakawa Y, Kawai H, Kimura Y, Seno K, Kosugi I, Katsumi K. Hirano A, et al. Among authors: kimura y. Nihon Shokakibyo Gakkai Zasshi. 2011 Oct;108(10):1705-11. Nihon Shokakibyo Gakkai Zasshi. 2011. PMID: 21971144 Japanese.

3

Coexpression of organic anion-transporting polypeptides 1B3 and multidrug-resistant proteins 2 increases the enhancement effect of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid on hepatocellular carcinoma in magnetic resonance imaging.

Kimura Y, Sato S, Hitomi E, Ohyama M, Adachi K, Inagaki Y, Yamakawa Y, Hirano A, Kawai H, Tsuchida K, Senoo K, Katsumi K, Joh T. Kimura Y, et al. Hepatol Res. 2014 Mar;44(3):327-37. doi: 10.1111/hepr.12128. Epub 2013 May 7. Hepatol Res. 2014. PMID: 23607695

4

Persistent reflux symptoms cause anxiety, depression, and mental health and sleep disorders in gastroesophageal reflux disease patients.

Kimura Y, Kamiya T, Senoo K, Tsuchida K, Hirano A, Kojima H, Yamashita H, Yamakawa Y, Nishigaki N, Ozeki T, Endo M, Nakanishi K, Sando M, Inagaki Y, Shikano M, Mizoshita T, Kubota E, Tanida S, Kataoka H, Katsumi K, Joh T. Kimura Y, et al. J Clin Biochem Nutr. 2016 Jul;59(1):71-7. doi: 10.3164/jcbn.16-9. Epub 2016 May 21. J Clin Biochem Nutr. 2016. PMID: 27499583 Free PMC article.

5

Phase II Prospective Study of Trastuzumab in Combination with S-1 and Oxaliplatin (SOX100) Therapy for HER2-Positive Advanced Gastric Cancer.

Mori Y, Kataoka H, Ebi M, Adachi K, Yamaguchi Y, Hayashi N, Hirata Y, Sobue S, Ishihara R, Suzuki Y, Mizushima T, Inoue Y, Hasegawa I, Ono S, Hirano A, Kimura Y, Seno K, Ozeki K, Shimura T, Kubota E. Mori Y, et al. Among authors: kimura y. J Gastrointest Cancer. 2022 Dec;53(4):930-938. doi: 10.1007/s12029-021-00711-0. Epub 2021 Sep 22. J Gastrointest Cancer. 2022. PMID: 34550548 Clinical Trial.

6

Efficacy of minocycline hydrochloride aspiration sclerotherapy with additional monoethanolamine oleate aspiration sclerotherapy for symptomatic hepatic cysts.

Kimura Y, Fujiwara K, Matsuura K, Suzuki T, Senoo K, Tsuchida K, Mori Y, Hirano A, Nomura S, Kitagawa M, Tomita Y, Kanaiwa H, Imazu M, Nagura Y, Nojiri S, Kataoka H. Kimura Y, et al. Hepatol Res. 2023 Mar;53(3):267-275. doi: 10.1111/hepr.13865. Epub 2022 Dec 15. Hepatol Res. 2023. PMID: 36479738

7

BRAF V600E-mutated Colorectal Neuroendocrine Carcinoma Effectively Treated with a Chemotherapy Protocol for BRAF-mutated Metastatic Colorectal Cancer: A Case Report.

Owaki S, Mori Y, Nakai S, Maeda H, Imazu M, Tomita Y, Kanaiwa H, Yamaguchi A, Kitagawa M, Hirano A, Kimura Y, Tsuchida K, Kataoka H. Owaki S, et al. Among authors: kimura y. Intern Med. 2023 Nov 20. doi: 10.2169/internalmedicine.2870-23. Online ahead of print. Intern Med. 2023. PMID: 37981300 Free article.

8

Adalimumab Dose-Escalation Therapy Is Effective in Refractory Crohn's Disease Patients with Loss of Response to Adalimumab, Especially in Cases without Previous Infliximab Treatment.

Suzuki T, Mizoshita T, Sugiyama T, Hirata Y, Kimura Y, Suzuki Y, Yamada T, Tsukamoto H, Mizushima T, Sugimura N, Katano T, Tanida S, Kataoka H, Sasaki M. Suzuki T, et al. Among authors: kimura y. Case Rep Gastroenterol. 2019 Feb 6;13(1):37-49. doi: 10.1159/000496453. eCollection 2019 Jan-Apr. Case Rep Gastroenterol. 2019. PMID: 31182942 Free PMC article.

9

The neutrophil-to-lymphocyte ratio at the start of the second course during atezolizumab plus bevacizumab therapy predicts therapeutic efficacy in patients with advanced hepatocellular carcinoma: A multicenter analysis.

Matoya S, Suzuki T, Matsuura K, Suzuki Y, Okumura F, Nagura Y, Sobue S, Kuroyanagi K, Kusakabe A, Koguchi H, Hasegawa I, Miyaki T, Tanaka Y, Kondo H, Kimura Y, Ozasa A, Kawamura H, Kuno K, Fujiwara K, Nojiri S, Kataoka H; Sakurayama Liver Study Group (SLSG). Matoya S, et al. Among authors: kimura y. Hepatol Res. 2023 Jun;53(6):511-521. doi: 10.1111/hepr.13886. Epub 2023 Feb 18. Hepatol Res. 2023. PMID: 36723964

10

Outcome of nucleos(t)ide analog cessation in patients with treatment for prevention of or against hepatitis B virus reactivation.

Suzuki T, Matsuura K, Urakabe K, Okumura F, Kawamura H, Sobue S, Matoya S, Miyaki T, Kimura Y, Kato D, Kusakabe A, Tanaka Y, Ozasa A, Nagura Y, Fujiwara K, Nojiri S, Hagiwara S, Kusumoto S, Inoue T, Tanaka Y, Kataoka H. Suzuki T, et al. Among authors: kimura y. Hepatol Res. 2023 Apr;53(4):289-300. doi: 10.1111/hepr.13864. Epub 2022 Dec 16. Hepatol Res. 2023. PMID: 36461885

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

5,852 results

Search Page